Investigation Report on Nicergoline in China, 2018-2022
DESCRIPTION
Nicergoline is a semi-synthetic ergoline derivative that plays as ?-blocker and can strengthen vascular systems, brain cell metabolism, oxygen and glucose digestion and dopamine conversion so that nerve conduction and brain function can be improved. Nicergoline was originally developed by Pfizer. It can be applied to a wide range of symptoms, so it became popular worldwide since its launch.
According to CRI's analysis, due to the expired patent of nicergoline in China, the market has been dominated by generic drugs. At present, there are many companies that produce nicergoline. Among them, Kunshan Rotam Reddy Pharmaceutical Co., Ltd. occupies a major share. Its market share exceeded 60% in 2017, and other manufacturers with high market occupancy include Pfizer, Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. and China Meheco Sanyang Pharma Co., Ltd. etc. In China, dosage forms of nicergoline include freeze-dried powder injections, capsules, tablets and injections. Manufacturers of tablets are in a great number. The main manufacturer of injections is Hainan General Kangli Pharmaceutical Co., Ltd., and the major manufacturers of capsules are Fuan Pharmaceuticals and China Meheco Sanyang Pharma Co., Ltd. etc.
According to CRI's analysis, nicergoline has been on the market for more than 40 years. Its market size and market share in anti-Alzheimer's drugs is not large due to the fierce competition. Its product life cycle has entered a maturity stage. In 2017, the sales value of nicergoline was approximately CNY 129 million, with a slight increase over 2016.
It is expected that from 2018 to 2022, due to competition from other types of anti-Alzheimer's drugs such as biopharmaceuticals, the market size of nicergoline will not grow rapidly but will remain flat or grow at a low rate. However, due to the lower average price, nicergoline is still active in the Chinese market. The sales of nicergoline will not drop significantly during 2018 to 2022 and will not be replaced by other drugs either.
TOPICS COVERED:
Nicergoline is a semi-synthetic ergoline derivative that plays as ?-blocker and can strengthen vascular systems, brain cell metabolism, oxygen and glucose digestion and dopamine conversion so that nerve conduction and brain function can be improved. Nicergoline was originally developed by Pfizer. It can be applied to a wide range of symptoms, so it became popular worldwide since its launch.
According to CRI's analysis, due to the expired patent of nicergoline in China, the market has been dominated by generic drugs. At present, there are many companies that produce nicergoline. Among them, Kunshan Rotam Reddy Pharmaceutical Co., Ltd. occupies a major share. Its market share exceeded 60% in 2017, and other manufacturers with high market occupancy include Pfizer, Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. and China Meheco Sanyang Pharma Co., Ltd. etc. In China, dosage forms of nicergoline include freeze-dried powder injections, capsules, tablets and injections. Manufacturers of tablets are in a great number. The main manufacturer of injections is Hainan General Kangli Pharmaceutical Co., Ltd., and the major manufacturers of capsules are Fuan Pharmaceuticals and China Meheco Sanyang Pharma Co., Ltd. etc.
According to CRI's analysis, nicergoline has been on the market for more than 40 years. Its market size and market share in anti-Alzheimer's drugs is not large due to the fierce competition. Its product life cycle has entered a maturity stage. In 2017, the sales value of nicergoline was approximately CNY 129 million, with a slight increase over 2016.
It is expected that from 2018 to 2022, due to competition from other types of anti-Alzheimer's drugs such as biopharmaceuticals, the market size of nicergoline will not grow rapidly but will remain flat or grow at a low rate. However, due to the lower average price, nicergoline is still active in the Chinese market. The sales of nicergoline will not drop significantly during 2018 to 2022 and will not be replaced by other drugs either.
TOPICS COVERED:
- Development environment of nicergoline in China
- Indication of nicergoline
- Sales of nicergoline in China
- Average price of nicergoline in China
- Analysis of nicergoline manufacturers in the Chinese market
- Prospects of Chinese nicergoline market from 2018 to 2022
- Forecast on sales value of nicergoline in China, 2018-2022
1 NICERGOLINE-RELATED CONCEPTS
1.1 Indication
1.2 Development of Nicergoline in China
2 OVERVIEW OF NICERGOLINE MARKETS
2.1 Patents and Drug Production Permission
2.2 Major Nicergoline Manufacturers in Chinese Market
3 SALES OF NICERGOLINE IN CHINA, 2013-2017
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value in Different Regions
3.2 Sales volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume in Different Regions
3.3 Market Share of Key Nicergoline Manufacturers
3.3.1 Market Share by Sales Value
3.3.2 Market Share by Sales Volume
3.4 Sales of Nicergoline in Different Dosage Forms
3.4.1 Market Share of Nicergoline Dosage Forms by Sales Value
3.4.2 Market Share of Nicergoline Dosage Forms by Sales Volume
4 ANALYSIS OF NICERGOLINE MANUFACTURERS, 2017-2018
4.1 Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
4.1.1 Enterprise Profile
4.1.2 Sales Value and Average Sales Price of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
4.2 Pfizer
4.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.
4.4 China Meheco Sanyang Pharma Co., Ltd.
4.5 Hainan General Kangli Pharmaceutical Co., Ltd.
4.6 Hainan Zambon Pharmaceutical Co.,Ltd
4.7 Pharmacia
4.8 Shandong Qidu Pharmaceutical Co., Ltd.
4.9 Shandong Fangming Pharmaceutical Group Co., Ltd.
4.10 Other Enterprises
5 PROSPECTS OF CHINESE NICERGOLINE MARKET, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Development Trend
PART OF CHARTS
Chart Approval Number of Domestically-produced Nicergoline
Chart Sales Value of Nicergoline, 2007-2017
Chart Sales Volume of Nicergoline, 2007-2017
Chart Sales Volume of Nicergoline in Different Regions, 2013-2017
Chart Sales Value and Market Share of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd., 2013-2017
Chart Sales Value and Market Share of Nicergoline of Pfizer, 2013-2017
Chart Sales Value and Market Share of Nicergoline Tablets in China, 2013-2017
Chart Sales Value and Market Share of Nicergoline Capsules in China, 2013-2017
Chart Sale Price of Nicergoline of Kunshan Rotam Reddy Pharmaceutical in Several Chinese Cities, 2017-2018
Chart Sale Price of Nicergoline of Pfizer in Several Chinese Cities, 2017-2018
Chart Forecast on Market Size of Nicergoline in China, 2018-2022
COMPANIES MENTIONED
1 Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
Pharmaceutical Co., Ltd.
2 Pfizer
3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.
4 China Meheco Sanyang Pharma Co., Ltd.
5 Hainan General Kangli Pharmaceutical Co., Ltd.
6 Hainan Zambon Pharmaceutical Co.,Ltd
7 Pharmacia
8 Shandong Qidu Pharmaceutical Co., Ltd.
9 Shandong Fangming Pharmaceutical Group Co., Ltd.
10 Other Enterprises
1.1 Indication
1.2 Development of Nicergoline in China
2 OVERVIEW OF NICERGOLINE MARKETS
2.1 Patents and Drug Production Permission
2.2 Major Nicergoline Manufacturers in Chinese Market
3 SALES OF NICERGOLINE IN CHINA, 2013-2017
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value in Different Regions
3.2 Sales volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume in Different Regions
3.3 Market Share of Key Nicergoline Manufacturers
3.3.1 Market Share by Sales Value
3.3.2 Market Share by Sales Volume
3.4 Sales of Nicergoline in Different Dosage Forms
3.4.1 Market Share of Nicergoline Dosage Forms by Sales Value
3.4.2 Market Share of Nicergoline Dosage Forms by Sales Volume
4 ANALYSIS OF NICERGOLINE MANUFACTURERS, 2017-2018
4.1 Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
4.1.1 Enterprise Profile
4.1.2 Sales Value and Average Sales Price of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
4.2 Pfizer
4.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.
4.4 China Meheco Sanyang Pharma Co., Ltd.
4.5 Hainan General Kangli Pharmaceutical Co., Ltd.
4.6 Hainan Zambon Pharmaceutical Co.,Ltd
4.7 Pharmacia
4.8 Shandong Qidu Pharmaceutical Co., Ltd.
4.9 Shandong Fangming Pharmaceutical Group Co., Ltd.
4.10 Other Enterprises
5 PROSPECTS OF CHINESE NICERGOLINE MARKET, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Development Trend
PART OF CHARTS
Chart Approval Number of Domestically-produced Nicergoline
Chart Sales Value of Nicergoline, 2007-2017
Chart Sales Volume of Nicergoline, 2007-2017
Chart Sales Volume of Nicergoline in Different Regions, 2013-2017
Chart Sales Value and Market Share of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd., 2013-2017
Chart Sales Value and Market Share of Nicergoline of Pfizer, 2013-2017
Chart Sales Value and Market Share of Nicergoline Tablets in China, 2013-2017
Chart Sales Value and Market Share of Nicergoline Capsules in China, 2013-2017
Chart Sale Price of Nicergoline of Kunshan Rotam Reddy Pharmaceutical in Several Chinese Cities, 2017-2018
Chart Sale Price of Nicergoline of Pfizer in Several Chinese Cities, 2017-2018
Chart Forecast on Market Size of Nicergoline in China, 2018-2022
COMPANIES MENTIONED
1 Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
Pharmaceutical Co., Ltd.
2 Pfizer
3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.
4 China Meheco Sanyang Pharma Co., Ltd.
5 Hainan General Kangli Pharmaceutical Co., Ltd.
6 Hainan Zambon Pharmaceutical Co.,Ltd
7 Pharmacia
8 Shandong Qidu Pharmaceutical Co., Ltd.
9 Shandong Fangming Pharmaceutical Group Co., Ltd.
10 Other Enterprises
